Skip to main content
Erschienen in: Medical Oncology 1/2014

01.01.2014 | Original Paper

The relationship between thyroid volume and malignant thyroid disease

verfasst von: Ayse Ocak Duran, Cuneyd Anil, Alptekin Gursoy, Aslı Nar, Ozden Altundag, Mevlude Inanc, Oktay Bozkurt, Neslihan Bascil Tutuncu

Erschienen in: Medical Oncology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

The present retrospective study aimed to investigate the relationship between thyroid volume and prevalence of thyroid cancer. We investigated the data of 3,850 patients who underwent fine-needle aspiration biopsy (FNAB). Biopsy results were evaluated as diagnostic or nondiagnostic, and diagnostic results were classified as benign, malignant, and indeterminate. We included 2,672 patients who underwent FNAB firstly in our hospital and evaluated as diagnostic biopsy except subgroup of indeterminate. We obtained cytologic data, levels of serum thyroid-stimulating hormone (TSH), and thyroid volumes of those patients retrospectively. Among 2,672 patients with thyroid nodule, 2,562 (95.9 %) patients had benign cytology and 110 (%4,1) patients had malignant cytology. There was no correlation between the malignancy and gender (p = 0.935), and patients with malignant cytology were younger (52 vs 59, p < 0.001). Also, TSH levels were higher in patients with malignant than benign cytology (p = 0.017). Median volume of right part, left part, and total thyroid for patients who had malignant cytology was significantly lower than patients who had benign cytology (8.3, 7.1, 15.9 vs 10.8 ml, 9.0 mml, 20.6 ml, respectively, p ≤ 0.001 for all parameters). The results demonstrated that thyroid cancer prevalence was higher in patients with low thyroid volume. According to our results, thyroid volume should be considered as a risk factor for malignancy in the evaluation of thyroid nodules.
Literatur
1.
Zurück zum Zitat Hung W, Anderson KD, Chandra RS, Kapur SP, Patterson K, Randolph JG, August GP. Solitary thyroid nodules in 71 children and adolescents. J Pediatr Surg. 1992;27(11):1407–9.PubMedCrossRef Hung W, Anderson KD, Chandra RS, Kapur SP, Patterson K, Randolph JG, August GP. Solitary thyroid nodules in 71 children and adolescents. J Pediatr Surg. 1992;27(11):1407–9.PubMedCrossRef
2.
Zurück zum Zitat Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab. 2006;91(11):4295–301.PubMedCrossRef Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab. 2006;91(11):4295–301.PubMedCrossRef
3.
Zurück zum Zitat Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91(9):3411–7.PubMedCrossRef Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91(9):3411–7.PubMedCrossRef
4.
Zurück zum Zitat American association of clinical endocrinologists and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. AACE/AME Task force on Thyroid Nodules. Endocrine Practice. 2006; 12: 63–100. American association of clinical endocrinologists and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. AACE/AME Task force on Thyroid Nodules. Endocrine Practice. 2006; 12: 63–100.
5.
Zurück zum Zitat American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.
6.
Zurück zum Zitat Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–607.PubMedCrossRef Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–607.PubMedCrossRef
7.
Zurück zum Zitat Raparia K, Min SK, Mody DR, Anton R, Amrikachi M. Clinical outcomes for “suspicious” category in thyroid fine-needle aspiration biopsy: Patient’s sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med. 2009;133(5):787–90.PubMed Raparia K, Min SK, Mody DR, Anton R, Amrikachi M. Clinical outcomes for “suspicious” category in thyroid fine-needle aspiration biopsy: Patient’s sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med. 2009;133(5):787–90.PubMed
8.
Zurück zum Zitat Mendelson AA, Tamilia M, Rivera J, Hier MP, Sherman M, Garfield N, Black MJ, Rochon L, Gologan O, Payne RJ. Predictors of malignancy in preoperative nondiagnostic biopsies of the thyroid. J Otolaryngol Head Neck Surg. 2009;38(3):395–400.PubMed Mendelson AA, Tamilia M, Rivera J, Hier MP, Sherman M, Garfield N, Black MJ, Rochon L, Gologan O, Payne RJ. Predictors of malignancy in preoperative nondiagnostic biopsies of the thyroid. J Otolaryngol Head Neck Surg. 2009;38(3):395–400.PubMed
9.
Zurück zum Zitat Thyroid fine needle aspiration (FNA) and cytology. Thyroid. 2003;13:80–86. Thyroid fine needle aspiration (FNA) and cytology. Thyroid. 2003;13:80–86.
10.
Zurück zum Zitat Pacini F, Castagna MG, Brilli L, Pentheroudakis G, ESMO Guidelines Working Group. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(5):214–9.CrossRef Pacini F, Castagna MG, Brilli L, Pentheroudakis G, ESMO Guidelines Working Group. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(5):214–9.CrossRef
11.
Zurück zum Zitat de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, Mazzaferri EL. Cystic thyroid nodules: the dilemma of malignant lesions. Arch Intern Med. 1990;150:1422–7.PubMedCrossRef de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, Mazzaferri EL. Cystic thyroid nodules: the dilemma of malignant lesions. Arch Intern Med. 1990;150:1422–7.PubMedCrossRef
12.
Zurück zum Zitat Yeh MW, Demircan O, Ituarte P, Clark OH. Falsenegative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid. 2004;14:207–15.PubMedCrossRef Yeh MW, Demircan O, Ituarte P, Clark OH. Falsenegative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid. 2004;14:207–15.PubMedCrossRef
13.
Zurück zum Zitat Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong SJ, Kim WB, Shong YK. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf). 2004;60:21–8.CrossRef Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong SJ, Kim WB, Shong YK. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf). 2004;60:21–8.CrossRef
14.
Zurück zum Zitat Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91:3411–7.PubMedCrossRef Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91:3411–7.PubMedCrossRef
15.
Zurück zum Zitat Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Vigneri R, Belfiore A. The IGF system in thyroid cancer: new concepts. Mol Pathol. 2001;54:121–4.PubMedCentralPubMedCrossRef Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Vigneri R, Belfiore A. The IGF system in thyroid cancer: new concepts. Mol Pathol. 2001;54:121–4.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev. 1998;19:673–716.PubMedCrossRef Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev. 1998;19:673–716.PubMedCrossRef
17.
Zurück zum Zitat Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentrations a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab. 2006;91:4295–301.PubMedCrossRef Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentrations a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab. 2006;91:4295–301.PubMedCrossRef
18.
Zurück zum Zitat Grote VA, Becker S, Kaaks R. Diabetes mellitus type 2: an independent risk factor for cancer. Exp Clin Endocrinol Diabetes. 2010;118:4–8.PubMedCrossRef Grote VA, Becker S, Kaaks R. Diabetes mellitus type 2: an independent risk factor for cancer. Exp Clin Endocrinol Diabetes. 2010;118:4–8.PubMedCrossRef
19.
Zurück zum Zitat Ciampolillo A, De Tullio C, Perlino E, Mairano E. The IGF-I axis in thyroid carcinoma. Curr Pharm Des. 2007;13:729–35.PubMedCrossRef Ciampolillo A, De Tullio C, Perlino E, Mairano E. The IGF-I axis in thyroid carcinoma. Curr Pharm Des. 2007;13:729–35.PubMedCrossRef
20.
Zurück zum Zitat Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peaples GE, Devesa SS. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics 1980–2005. Cancer Epidemiol Biomarkers. 2009;18:784–91.CrossRef Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peaples GE, Devesa SS. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics 1980–2005. Cancer Epidemiol Biomarkers. 2009;18:784–91.CrossRef
Metadaten
Titel
The relationship between thyroid volume and malignant thyroid disease
verfasst von
Ayse Ocak Duran
Cuneyd Anil
Alptekin Gursoy
Aslı Nar
Ozden Altundag
Mevlude Inanc
Oktay Bozkurt
Neslihan Bascil Tutuncu
Publikationsdatum
01.01.2014
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 1/2014
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-013-0814-2

Weitere Artikel der Ausgabe 1/2014

Medical Oncology 1/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.